B
Bruce Neal
Researcher at The George Institute for Global Health
Publications - 620
Citations - 109123
Bruce Neal is an academic researcher from The George Institute for Global Health. The author has contributed to research in topics: Population & Blood pressure. The author has an hindex of 108, co-authored 561 publications receiving 87213 citations. Previous affiliations of Bruce Neal include National Institutes of Health & University of the Western Cape.
Papers
More filters
Journal ArticleDOI
The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials.
Sébastien Czernichow,Alberto Zanchetti,Fiona Turnbull,Federica Barzi,Toshiharu Ninomiya,Andre Pascal Kengne,Hiddo J.L. Heerspink,Vlado Perkovic,Rachel R. Huxley,Hisatomi Arima,Anushka Patel,John Chalmers,Mark Woodward,Stephen MacMahon,Bruce Neal +14 more
TL;DR: The findings suggest that additional blood pressure reduction in hypertensive patients meeting initial blood pressure targets will produce further benefits, and the data are supportive of the utilization of blood pressure-lowering regimens in high-risk patients with and without hypertension.
Journal ArticleDOI
Monitoring and benchmarking government policies and actions to improve the healthiness of food environments: a proposed Government Healthy Food Environment Policy Index.
Boyd Swinburn,Stefanie Vandevijvere,Vivica I. Kraak,Gary Sacks,Wendy Snowdon,Corinna Hawkes,Simon Barquera,Sharon Friel,Bridget Kelly,Shiriki K. Kumanyika,Mary R. L’Abbé,Andy Lee,Tim Lobstein,J. Ma,J. Macmullan,Sailesh Mohan,Carlos Augusto Monteiro,Bruce Neal,Mike Rayner,David Sanders,Celeste Walker +20 more
TL;DR: A monitoring framework to assess government policies and actions for creating healthy food environments and benchmarking of government policy implementation has the potential to catalyse greater action to reduce obesity and NCDs.
Journal ArticleDOI
Omega 3 Fatty Acids and Cardiovascular Outcomes Systematic Review and Meta-Analysis
TL;DR: &ohgr;-3 FA may protect against vascular disease, but the evidence is not clear-cut, and any benefits are almost certainly not as great as previously believed.
Journal ArticleDOI
Effects of Perindopril-Based Lowering of Blood Pressure on Intracerebral Hemorrhage Related to Amyloid Angiopathy The PROGRESS Trial
Hisatomi Arima,Christophe Tzourio,Craig S. Anderson,Mark Woodward,Marie-Germaine Bousser,Stephen MacMahon,Bruce Neal,John Chalmers +7 more
TL;DR: BP-lowering treatment is likely to provide protection against all types of ICH, and there was no evidence of differences in the magnitude of the effects of treatment among different types ofICH.
Journal ArticleDOI
Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial.
A. Michael Lincoff,Jean-Claude Tardif,Gregory G. Schwartz,Stephen J. Nicholls,Lars Rydén,Bruce Neal,Klas Malmberg,Klas Malmberg,Hans Wedel,John B. Buse,Robert R. Henry,Arlette Weichert,Ruth Cannata,Anders Svensson,Dietmar Volz,Diederick E. Grobbee +15 more
TL;DR: Findings do not support the use of aleglitazar in this setting with a goal of reducing cardiovascular risk and the trial was terminated on July 2, 2013 due to futility for efficacy at an unplanned interim analysis and increased rates of safety end points.